载脂蛋白E
巨噬细胞
CD8型
免疫检查点
免疫系统
医学
T细胞
癌症免疫疗法
癌症
生物
癌症研究
体外
免疫学
免疫疗法
内科学
生物化学
疾病
作者
Chuan Liu,Jindong Xie,Bo Lin,Weihong Tian,Yifan Wu,Xin Shan,Libing Hong,Xin Li,Lulu Liu,Yuzhi Jin,Hailin Tang,Xinpei Deng,Yutian Zou,Shaoquan Zheng,Weijia Fang,Jinlin Cheng,Xiaomeng Dai,Xuanwen Bao,Peng Zhao
标识
DOI:10.1002/advs.202401061
摘要
Abstract The heterogeneity of macrophages influences the response to immune checkpoint inhibitor (ICI) therapy. However, few studies explore the impact of APOE + macrophages on ICI therapy using single‐cell RNA sequencing (scRNA‐seq) and machine learning methods. The scRNA‐seq and bulk RNA‐seq data are Integrated to construct an M.Sig model for predicting ICI response based on the distinct molecular signatures of macrophage and machine learning algorithms. Comprehensive single‐cell analysis as well as in vivo and in vitro experiments are applied to explore the potential mechanisms of the APOE + macrophage in affecting ICI response. The M.Sig model shows clear advantages in predicting the efficacy and prognosis of ICI therapy in pan‐cancer patients. The proportion of APOE + macrophages is higher in ICI non‐responders of triple‐negative breast cancer compared with responders, and the interaction and longer distance between APOE + macrophages and CD8 + exhausted T (Tex) cells affecting ICI response is confirmed by multiplex immunohistochemistry. In a 4T1 tumor‐bearing mice model, the APOE inhibitor combined with ICI treatment shows the best efficacy. The M.Sig model using real‐world immunotherapy data accurately predicts the ICI response of pan‐cancer, which may be associated with the interaction between APOE + macrophages and CD8 + Tex cells.
科研通智能强力驱动
Strongly Powered by AbleSci AI